Live Breaking News & Updates on Jinsheng Ren

Stay updated with breaking news from Jinsheng ren. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Simcere and Connect Enter into an exclusive license and collaboration agreement for the innovative autoimmune drug Rademikibart

On November 21, 2023, Simcere Pharmaceutical Group Limited ("Simcere") entered into an exclusive license and collaboration agreement (the "Agreement") with Connect Biopharma HongKong Limited ("Connect") in relation to Rademikibart, an innovative IL-4Rα monoclonal antibody. ....

Jinsheng Ren , Duplizumab Dupixent , Simcere Pharmaceutical Group , Drug Administration , Greater China , Pharmaceutical Group , Connect Biopharma Hongkong Limited , Inflammatory Diseases , Clinical Trial , Greater China , Simcere Pharmaceutical Group Limited , Synergistic Effect , Commercialization Efforts , Monoclonal Antibody ,

Connect Biopharma (CNTB) and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China

Connect Biopharma (CNTB) and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Zheng Wei , Hong Kong , Jinsheng Ren , Biopharma Hong Kong , Simcere Pharmaceutical Co Ltd , Biopharma Holdings Limited Nasdaq , Simcere Pharmaceutical Group Ltd , Suzhou Connect Biopharma Co Ltd , Connect Biopharma Holdings Limited , Connect Biopharma Hong Kong Limited , Simcere Pharmaceutical Group , Connect Biopharma , Greater China ,

Idorsia's Daridorexant: Company Enters Into Licensing Agreement

Idorsia entered into a licensing agreement in China for Idorsia's daridorexant, an orexin antagonist medication used for insomnia. ....

Hong Kong , Jinsheng Ren , Jean Paul Clozel , Simcere Pharmaceuticals , National Medical Products Administration , Mainland China , Chief Executive Officer ,